HOME >> BIOLOGY >> NEWS
Experts Say That Future Inhaled Anti-Viral Drug, Zanamivir Is Effective For,,Treatment And Prevention Of Influenza

28 September 1998: Experts have released new scientific information at a medical conference in the US which shows that an inhaled influenza drug, zanamivir, is effective for both treatment and prevention of the influenza infection.

"Zanamivir is a new antiviral that stops influenza dead in its tracks," said Professor Chris Silagy, Flinders Medical Centre, South Australia. "It is given by the inhaled route so the medicine goes straight to where the influenza virus infects the body -- in the breathing passages. By inhaling zanamivir, the drug gets to the site of infection faster than taking it by mouth."

New information from two phase III clinical trials was presented at the meeting*. The findings from the treatment trial, conducted in Australia, New Zealand and South Africa were:

  • Patients treated with the inhaled drug zanamivir experienced a significant reduction in the severity of their symptoms (such as feverishness, cough, weakness, aches and pains), so much so that they recovered from the illness on average as much as 2.5 days earlier than those who did not receive the drug.

  • Patients at risk of developing complications (which can include pneumonia, bronchitis and pleurisy) as a result of having influenza, experienced a 70 per cent reduction in complications if given zanamivir.

  • Patients on zanamivir experienced no more side-effects than those on placebo (a dummy version of the medicine).

Overall, patients taking zanamivir felt:

  • Their health improved more quickly.
  • They could get back to normal activities more quickly.

In a second trial conducted in the US, where patients took zanamivir once a day for 28 days to prevent flu, it was found that:

Two thirds of patients who had not been vaccinated against influenza and were given zanamivir were protected from being ill with flu. Those patients who did get ill were less likely to develop illness with fever when receiving zanamivir.


'"/>

Contact: Helen Walicka
0802 613 018-Mobile
CPR Worldwide
28-Sep-1998


Page: 1 2

Related biology news :

1. Experts to lecture in US cities this spring about new human origins research
2. Experts to demonstrate latest, cost-cutting computer-based caregiving for older Americans
3. Experts deliver foot and mouth disease warning
4. Experts offer the skinny on search for healthy fat
5. Experts discuss recommendations of NY state task force on genetic testing
6. Expanded Global Change Experts Directory available
7. Experts to share biotech future world
8. NASA Materials Conference Features Science Results, Experts on Technologies for Exploration
9. Experts meet to evaluate watershed restoration for salmon in Pacific rivers
10. Experts say independent scientific panels useful in advising judges in complex cases
11. Experts say diet and exercise play critical role in cancer prevention

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2018)... (PRWEB) , ... November 07, 2018 , ... ... research and advisory firm serving the life science industry. The event was attended ... of science” that advance biological research and drug discovery. The winners were determined ...
(Date:11/3/2018)... ... November 01, 2018 , ... ... New Challenges and New Opportunities, **Presented by FDAnews**, Dec. 6, 2018 – Kleinfeld, ... , Early bird pricing for Emerging Trends in Medical Device Regulation and Quality ...
(Date:10/31/2018)... TRIANGLE PARK, N.C. (PRWEB) , ... October 30, ... ... the appointment of Brad Heidinger to Director of Operations. With more than 20 ... executive with proven visionary leadership in the biomanufacturing industry. Heidinger joins Azzur from ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... GlycoMark, Inc., the ... professionals through its website, http://www.glycomark.com , as part of National Diabetes Month. ... option via the website in November from 9 a.m. – 5 p.m. ET ...
(Date:10/31/2018)... ... October 30, 2018 , ... Myoscience, ... at the Campbell Clinic in Memphis, Tennessee. This study enrolled 125 patients ... of care for managing pain after total knee replacement surgery (TKA). , The ...
(Date:10/25/2018)... ... October 24, 2018 , ... To prepare for radiological and ... will work Argentum Medical, LLC to repurpose its commercial Silverlon ® ... technology, the privately held company has been awarded a three-year, $8.4 million contract with ...
(Date:10/18/2018)... ... October 18, 2018 , ... R3 Stem Cell is ... day regenerative therapy training workshop. The discount is good through November 7th, 2018, with ... stem cell and PRP training workshop includes an amazing useful array of hands on ...
Breaking Biology Technology:
Cached News: